To conduct phase i, II, III or IV contraceptive trials in women, treatment trials of gynecologic conditions such as endometriosis or leiomyomata, and development of research protocols on a task…

Active Indefinite Delivery Contract Awarded Last action

Contract number
75N94020D00016
Awardee
Awarding agency
Task orders
5 $1,960,042 obligated

Award facts

Combined order value
  • $2,141,083 Current, with exercised options
  • $2,241,924 Potential, with all options
Last date to order 89% complete
IDV ceiling 39% used
$5,000,000.00
Award type
Multiple award
Who can order
Only the awarding agency
Set-aside
No set-aside
Competition
Full and Open Competition · 18 offers Negotiated Proposal / Quote
Pricing
Cost No Fee

Award details come from SAM.gov/FPDS.

About this IDV

The National Institutes of Health's National Institute of Child Health and Human Development awarded Oregon Health & Science University an indefinite delivery contract with a potential value of $5,000,000 to conduct clinical trials in support of contraceptive development. Task orders issued against this contract include protocols for Phase 1 evaluation of the Ovaprene device ($181k), central laboratory services for pharmacokinetic analysis of levonorgestrel butanoate ($349k), and assistance with protocol review and development activities ($91k).

Work performed under the contract advances the National Institute of Child Health and Human Development's Contraceptive Development Program goals by supporting the Contraceptive Clinical Trials Network through clinical evaluation of reproductive health technologies. Task orders issued to Oregon Health & Science University involve finalizing trial protocols, obtaining regulatory approvals, and initiating recruitment activities in Portland, Oregon for early-stage contraceptive device and drug evaluation studies. The indefinite delivery contract was awarded on August 1, 2020 and has a period of performance through July 31, 2027.

Description

To conduct phase i, II, III or IV contraceptive trials in women, treatment trials of gynecologic conditions such as endometriosis or leiomyomata, and development of research protocols on a task order basis under a seven (7) year indefinite-delivery

Task orders

Transactions

Action Obligated Date
Other Administrative Action P00003 $0
Other Administrative Action P00002 · Female sites edited by koomsont_NIH on 11/23/2021 20:28:00 edited by pagana_NIH on 11/29/2021 19:03:29 $0
Other Administrative Action P00001 · Contraceptive development program: nichd contraceptive clinical trials network - female sites $0
Original award $0

Subawards

Subcontractor Amount Awarded
Boston Medical Center Corporation TO CONDUCT PHASE I, II, III OR IV CONTRACEPTIVE TRIALS IN WOMEN, TREATMENT TRIALS OF GYNECOLOGIC CONDITIONS SUCH AS ENDOMETRIOSIS OR LEIOMYOMATA, AND… $23,460

Quick answers

Who was awarded contract 75N94020D00016?

75N94020D00016 was awarded to Oregon Health & Science University by National Institute of Child Health and Human Development (National Institutes of Health) on August 1, 2020.

How much is contract 75N94020D00016 worth?

Orders under 75N94020D00016 have obligated $1,960,042. Their combined current value, with exercised options, is $2,141,083. Their combined potential value, with all options, is $2,241,924. 75N94020D00016's own ceiling is $5,000,000.

How many orders have been placed under contract 75N94020D00016?

5 orders have been placed under 75N94020D00016, the latest on August 1, 2025.

Who can order from contract 75N94020D00016?

75N94020D00016 is a multiple award indefinite delivery contract. Only the awarding agency can place orders on it.

Was contract 75N94020D00016 competed?

The extent of competition for 75N94020D00016 was full and open competition. The government received 18 offers.

On GovTribe

See this IDV's full record

  • Every order and transaction
  • The awardee's other awards and teaming partners
  • Similar IDVs and recompete opportunities
  • Ask GovTribe AI about this IDV